http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013150298-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-483 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G09B23-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28 |
| filingDate | 2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013150298-A |
| titleOfInvention | SIGMA-1 AGONIST OF AFOBAZOL RECEPTORS-A NEW MEDICINAL PREVENTION FOR PREVENTION OF EXCEPTIONAL CARDIAC MORTALITY IN PATIENTS AFFECTING ALCOHOLIC CARDIOMYOPATHY AND METHOD OF ITS MODEL |
| abstract | 1. The use of 5-ethoxy-2- [2- (morpholino) -ethylthio] benzimidazole dihydrochloride - afobazole - as a means for the prevention of sudden cardiac death in alcoholic cardiomyopathy. 2. A method for modeling alcoholic cardiomyopathy, which consists in forced alcoholization of animals with a 10% aqueous solution of ethanol for 13 weeks, the subsequent selection of animals with a high preference for alcohol and continued alcoholization until the end of 6 months from the start of alcoholization. |
| priorityDate | 2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.